Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KD-357 Phase III Study
jRCT2080222145Phase 3
- Sponsor
- The Chemo-Sero-Therapeutic Research Institute
- Start
- Jul 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3 trial of KD-357 in rabies (2 arms), sponsored by The Chemo-Sero-Therapeutic Research Institute.
02
Drugs
KD-357
03
Conditions
rabies
Beyond the preview
Go deeper on jRCT2080222145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222145.